Biological treatment in systemic juvenile idiopathic arthritis: achievement of inactive disease or clinical remission on a first, second or third biological agent

OBJECTIVES: To analyse the effect of biological agents (BAs) in terms of achieving inactive disease (ID) or clinical remission (CR) in patients with systemic juvenile idiopathic arthritis (SJIA), to describe effects of switching or discontinuing a BA and to assess the proportion of patients able to...

Descripción completa

Detalles Bibliográficos
Autores principales: Woerner, A, Uettwiller, F, Melki, I, Mouy, R, Wouters, C, Bader-Meunier, B, Quartier, P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Paediatric Rheumatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613174/
https://www.ncbi.nlm.nih.gov/pubmed/26509061
http://dx.doi.org/10.1136/rmdopen-2014-000036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613174/
https://www.ncbi.nlm.nih.gov/pubmed/26509061
http://dx.doi.org/10.1136/rmdopen-2014-000036

Ejemplares similares